Abstract
Hepatitis C virus is very common amongst population infected with viral hepatitis. A very important point before deciding on the correct treatment is the stage of illness. More people are detected too late, and therefore the treatment was not efficient. A highly sensitive and selective screening system for early detection is needed in order to cure the patient cured. Therefore, this review is summarizing new methods of detection of specific biomarkers/genotypes for viral hepatitis C, to help find the highest sensitive screening methods that may influence the decision of the most efficient treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
